Integrated BioPharma (INBP) Insider Milmoe Buys 50,000 Shares
William Milmoe purchased 50,000 shares of INBP on June 24, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
William Milmoe bought 50,000 shares of Integrated BioPharma, Inc. ($INBP) on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $INBP is up 0.0% after 1 week, down 11.1% after 1 month and up 0.0% to date (from the $0.18 close on Jun 24, 2026).
INBP
Integrated BioPharma, Inc.
Key Points
- William Milmoe bought 50,000 shares of INBP on June 24, 2026, with no disclosed transaction value.
- Shares of INBP traded near $0.18 on Thursday, but no further company financials were provided.
- Other insiders, including Damon DeSantis and Eric Friedman, also bought 50,000 shares each on the same date.
Get $INBP trade alerts by text
We text you when insiders, Congress or big funds trade $INBP. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Integrated BioPharma, Inc. alert may contain errors. Disclosures
William Milmoe recently bought 50,000 shares of INBP on June 24, 2026. The transaction did not disclose a specific price or total value, but it was not part of a pre-planned trading program.
Insider Buying and Selling at Integrated BioPharma, Inc.
The recent insider buying at INBP wasn't limited to William Milmoe. On the same day, Damon DeSantis, Eric Friedman, and Robert Canarick each acquired 50,000 shares. These transactions were also not part of any pre-arranged trading plans. Earlier in the year, on April 15, 2026, William Milmoe sold 11,201,964 shares, though no specific price was noted for that transaction.
Shares of INBP were trading around $0.18 on Thursday, but further details about the company's financials or market performance aren't available at this time.
Bottom Line
The recent insider activity at INBP shows a notable amount of buying by several insiders, including William Milmoe. Insider transactions are often closely watched by investors for potential signals about the company's future. However, without more financial details or analyst ratings, it's challenging to draw broader conclusions about INBP's market position.
Related Filing Alerts
Source: William Milmoe's Form 4 filing on $INBP (Jun 24, 2026). Find the original filing: INBP Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts